-
Definitive Healthcare Corp (DH) PT Lowered to $3.50 at Goldman Sachs
-
Definitive Healthcare Corp. (DH) Tops Q3 EPS by 1c
-
BofA Securities Out Positive on Definitive Healthcare Corp (DH): 'Setting the stage for market growth recovery'
-
Definitive Healthcare Corp (DH) PT Raised to $6 at Stifel
-
Definitive Healthcare Corp (DH) PT Raised to $3.80 at Goldman Sachs
-
Definitive Healthcare Corp. (DH) Tops Q2 EPS by 2c, provides guidance
-
BTIG Downgrades Definitive Healthcare Corp (DH) to Neutral
-
Definitive Healthcare Corp. (DH) Misses Q1 EPS by 97c
-
Definitive Healthcare Corp (DH) PT Lowered to $3 at Goldman Sachs
-
Definitive Healthcare Corp. (DH) Misses Q4 EPS by 58c
-
Barclays Downgrades Definitive Healthcare Corp (DH) to Underweight
-
Definitive Healthcare Corp. (DH) Reports Q3 Loss of $1.12
-
Definitive Healthcare Corp (DH) PT Lowered to $5 at Canaccord Genuity
-
BTIG Starts Definitive Healthcare Corp (DH) at Buy
-
Definitive Healthcare Corp. (DH) Misses Q2 EPS by 190c
-
Definitive Healthcare Corp (DH) PT Lowered to $8 at Goldman Sachs
-
JPMorgan Downgrades Definitive Healthcare Corp (DH) to Underweight

